2 results match your criteria: "John Radcliffe Hospital II[Affiliation]"
Expert Opin Ther Targets
August 2001
Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital II, Headington, OX3 9DU, UK.
The prospect of developing 'magic bullets' to attack tumour cells has been a goal of biologists for decades. Abundant experimental and clinical observations demonstrating that an effective specific immune response may engender tumour regression has prompted efforts to find an immunotherapeutic approach to this problem. The most important arm of cellular immunity for such responses appears to be cytotoxic T-lymphocytes (CTL) which can recognise antigen on virtually all cell types and which are key to the elimination of virally-infected cells.
View Article and Find Full Text PDFNeuropathol Appl Neurobiol
October 1990
Department of Paediatrics, John Radcliffe Hospital II, University of Oxford.
The origin of the microglia has long been a subject of debate. However it is now clear that monocytes enter the normal central nervous system and follow a series of morphological transformations as they differentiate into microglia. Thus, microglia are of monocytic origin.
View Article and Find Full Text PDF